IsoRay, Inc Stock News

IsoRay (ISR) delivered earnings and revenue surprises of 0.00% and 4.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

RICHLAND, Wash., May 12, 2020 -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding treatment options.

Isoray, Inc. (NYSE American: ISR) today announced that the Centers for Medicare and Medicaid Services (CMS) has approved 64 ICD-10-PCS billing codes used for reimbursement of Cesium-131 (Cesium Blu™

Capstone Mining made good progress in Q1 on its Cozamin expansion - however, delays caused by COVID-19 are likely. Now the low-cost Cozamin mine is temporarily

The

IsoRay (ISR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, today announced that it will host a conference

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Even the best technologies are useless if no one uses them, says our columnist. And that's especially true for contact tracing.

Step 2 CS is a high-risk test in the setting of COVID-19 with unproven benefits that do not justify the tradeoff.

The Government has allayed fears that the education calendar might face drastic alterations over the COVID-19 pandemic that led to school closures. Education Cabinet Secretary Prof. George Magoha on M